Antineoplastic and immunosuppressive drugs. 3. Adverse effects and therapeutic problems.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000505:Alopecia / Q000139:chemically induced; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002273:Carcinogens; D056486:Chemical and Drug Induced Liver Injury; D004351:Drug Resistance; D005260:Female; D006321:Heart / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D007239:Infections / Q000150:complications; D007246:Infertility / Q000139:chemically induced; D007674:Kidney Diseases / Q000139:chemically induced; D008297:Male; D009092:Mucous Membrane / Q000187:drug effects; D009153:Mutagens; D009325:Nausea / Q000139:chemically induced; D009369:Neoplasms / Q000150:complications; D010182:Pancreatic Diseases / Q000139:chemically induced; D011658:Pulmonary Fibrosis / Q000139:chemically induced; D012871:Skin Diseases / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D000970:Antineoplastic Agents; D002273:Carcinogens; D007166:Immunosuppressive Agents; D009153:Mutagens